AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Fulcrum Therapeutics, Inc. Director's Dealing 2021

Apr 2, 2021

32881_dirs_2021-04-02_d688fed1-77c5-4293-bcbc-92dbc6bafb36.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Fulcrum Therapeutics, Inc. (FULC)
CIK: 0001680581
Period of Report: 2021-03-23

Reporting Person: Dunn Judith (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct